» Articles » PMID: 21791838

Radiologic and Neuroradiologic Findings in the Mucopolysaccharidoses

Overview
Publisher Sage Publications
Date 2011 Jul 28
PMID 21791838
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The mucopolysaccharidoses (MPS) represent a group of inheritable, clinically heterogeneous lysosomal storage disorders, in which progressive accumulation of glycosaminoglycans (GAGs) can affect organs and tissues all over the body. The current paper discusses the skeletal X-ray and neuroimaging findings in MPS patients, and the imaging techniques that can be used for diagnosing and monitoring abnormalities in the skeleton and central nervous system. Most MPS types show a typical radiologic expression, called dysostosis multiplex, which manifests as malformations of the skeletal system involving bones in the skull, thorax, spine, pelvis, long bones, and hands. Abnormalities of the spine and GAG deposits in the meninges surrounding the spinal cord can result in spinal cord compression, which, if untreated, can lead to compressive myelopathy. Magnetic resonance imaging (MRI) is the most powerful imaging technique for detecting spinal cord compression, but also radiography and computed tomography are useful. GAG deposits in the brain and surrounding tissues can result in brain anomalies, i.e. white matter lesions, brain atrophy, and hydrocephalus, which can be detected using MRI. Skeletal X-ray and neuroimaging findings can play an important role in diagnosis, follow-up, surgical or medical planning, and assessment of treatment response in MPS patients. There is a need for standardized procedures in evaluating and monitoring neurologic complications in these patients.

Citing Articles

Intracranial tumor in a patient with mucopolysaccharidosis type 1 (Scheie syndrome): An extremely rare combination.

Kukreja S, Soomro A, Lohana S, Kalwar A, Ochani S, Rachna Heliyon. 2024; 10(19):e38652.

PMID: 39397911 PMC: 11471181. DOI: 10.1016/j.heliyon.2024.e38652.


Atypical Neuroimaging Findings in a Patient With Mucopolysaccharidosis Type VII (Sly Syndrome).

Lamghare P, Agarwal U, Kalekar T, Krishnani K Cureus. 2024; 16(8):e66819.

PMID: 39280482 PMC: 11393383. DOI: 10.7759/cureus.66819.


Mucopolysaccharidosis Type 1 among Children-Neuroradiological Perspective Based on Single Centre Experience and Literature Review.

Machnikowska-Sokolowska M, Myszczuk A, Wieszala E, Wieja-Blach D, Jamroz E, Paprocka J Metabolites. 2023; 13(2).

PMID: 36837830 PMC: 9962124. DOI: 10.3390/metabo13020209.


Increased ocular wall thickness and decreased globe volume in children with mucopolysaccharidosis type VI.

Ozkale Yavuz O, Ayaz E, Yildiz Y, Karaosmanoglu A, Bulut E, Kalkanoglu Sivri H Diagn Interv Radiol. 2022; 28(5):516-521.

PMID: 36218154 PMC: 9682595. DOI: 10.5152/dir.2022.21372.


Adjunct diagnostic value of radiological findings in mucopolysaccharidosis type IVa-related thoracic spinal abnormalities: a pilot study.

Jan Y, Tsai P, Huang W, Huang S, Liu Y, Cheng S Orphanet J Rare Dis. 2022; 17(1):296.

PMID: 35906705 PMC: 9335988. DOI: 10.1186/s13023-022-02449-9.